Tag: <span>Depression</span>

MARCH 31ST, 2025POSTED BY EMORY UNIVERSITY (Credit: Getty Images) SHARE THIS  ARTICLE You are free to share this article under the Attribution 4.0 International license. TAGS UNIVERSITY  EMORY UNIVERSITY A study suggests that levodopa, a medication that increases dopamine levels in the brain, may help treat individuals with depression who experience motivational impairments due to high inflammation....

by King’s College London Credit: CC0 Public Domain Depression is a mental health condition that affects 280 million people worldwide. It is twice as common in women than men and this pattern starts to develop during adolescence. Researchers have studied the biological processes that drive depression in adults and have shown a potential role for the...

Mixed methods study found hopelessness among patients struggling with condition after trying multiple antidepressantsPeer-Reviewed Publication University of Birmingham FacebookXLinkedInWeChatBlueskyMessageWhatsAppEmail Almost half of patients diagnosed with depression classify as being ‘treatment-resistant’ as new research suggests that many don’t respond to multiple antidepressant options. The new study, published in the British Journal of Psychiatry was led by academics from...

by Jennifer Johnson McEwen, Emory University Credit: Emory University School of Medicine A study from Emory University suggests that levodopa, a medication that increases dopamine levels in the brain, may help treat individuals with depression who experience motivational impairments due to high inflammation. Researchers found that a common blood test measuring C-reactive protein (CRP), a blood...

Edited by Anushree Chaphalkar March 06, 2025 054 TOPLINE: Depression was associated with having more physical health conditions at baseline, as well as faster development of additional conditions, in a new study. METHODOLOGY: TAKEAWAY: IN PRACTICE: “Existing healthcare systems are largely designed to treat individual conditions, instead of individual people with multiple conditions,” the investigators...

by Elana Gotkine For older adults with type 2 diabetes (T2D), use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a modestly lower risk for depression compared with dipeptidyl peptidase-4 inhibitor (DPP-4i) use, according to a study published online Feb. 25 in the Annals of Internal Medicine. Huilin Tang, Ph.D., from the University of Florida College...

by University of Helsinki Credit: Pixabay/CC0 Public Domain Psychotic-like experiences resemble symptoms of psychosis, but are milder, less frequent and much more common than psychotic disorders. While these symptoms do not constitute a disorder diagnosed as psychosis, they can still be disruptive, distressing or detrimental to functional capacity. Typical psychotic-like experiences include perceptual distortions and hallucinations,...

by Ellen Goldbaum, University at Buffalo These images demonstrate the different binding sites in NMDA receptors that the UB team has discovered are responsible for ketamine’s distinct clinical effects, as an anesthetic at high doses and as an anti-depressant at very low doses. The image on the left shows ketamine bound in the central pore of...